Viral Cancer Research - 1959

Surgeon Fired by Son’s Death Finds Virus May Cause Cancer

ATLANTIC CITY, Sept. 28 - When Dr. James T. Grace yr. watched his two-year old son die of leukemia in 1955, the medical part of his mind thought of one thing: infection. Healthy, playful one day, the child’s temperature shot up to 105 degrees the next; his glands swelled; he became toxic and in a few months he was dead.

So Dr. Grace gave up his private practice of surgery in Nashville, Tenn., and set out to discover if leukemia, the blood cancer that killed James T. Grace 3d, was caused by a germ — a virus perhaps. He moved to the Roswell Park Cancer Research Institute in Buffalo, N.Y.    Today Dr. Grace told the American College of Surgeons’ annual meeting here that he has evidence that not only leukemia but other human cancers as well may be caused by an infectious agent.

By grinding up malignant cancers cut from leukemia and other cancer victims, Dr. Grace and his Buffalo colleagues have infected mice with the human disease. They are first to do it on a large scale. Their evidence suggests but does not prove that a virus may be the culprit in the human ailment in the same way that the viruses caused the disease in animals. It is an infection; however, it is a strange kind of infection: you have to get it before or soon after birth.

So important do scientists consider the new finding that $500,000 has been obtained to narrow the search for the cancer-causing agent. Twenty-five scientists and technicians now work with thousands of mice, hamsters and monkeys. And the virus work now dominates a new building at the Buffalo institute.

Telling the story to his fellow surgeons, Dr. Grace said that many cancers in mice, rabbits and other species can be brought on by viruses. These ultramicroscopic bundles of chemicals, which in some forms are responsible for polio, colds and a host of other diseases, usually can be recovered from the growing animal cancer. Injected into another animal, the viruses caused the malignant disease there.

But there is only one case in which a “virus-like” substance recovered from human leukemia had produced a leukemia in mice. Whether that virus actually came from the human tissue or was a contaminant is still a matter of controversy. About three years ago, Dr. Grace discovered a chemical difference bewteen normal human tissue and cancer tissue. In trying to run down the difference, Dr. Grace’s mind again turned to infection with viruses as a possibility.

Why not try infecting mice with human cancers? Other scientists were able to do this by blasting the mice with X-rays or chemicals and then transplanting a lump of cancer flesh. There was only the one doubtful case on record of a virus recovery from a human being. Dr. Grace then recalled the experiments of Dr. Ludwig Gross of the Veterans Administration Hospital in the Bronx, N.Y. Dr. Gross could transfer a virus cancer from mouse to mouse by injecting cancer extracts — not lumps of tissue — into the new-born animal, a creature literally as big as a peanut.

Dr. Grace decided to try it with extracts of human cancer. First he ground up human cancer tissue removed at surgery. Next he extracted the solid matter and all cells. To make sure there was no solid matter left, he filtered the extract. Only a virus or a non-living chemical could slip through the filter’s fine pores. He injected about 1,000 new-born mice and waited for cancers.

To make sure he wasn’t deluding himself, Dr. Grace kept a controlled group of the same family of mice. He also tried to “grow” a human cancer virus in test tubes and injected that stuff too. But neither group developed the malignant disease. The mice injected with the filtered extracts of living cancer did develop cancer, particularly pregnant mice. Although Dr. Grace took his tissue from twenty different human cancers, most of the diseased mice developed malignant breast growths.

What is Dr. Grace looking for now? He and his colleagues, Dr. J.A. DiPaolo, Dr. E.A. Mirand, both Ph.D.’s, and J.R. Haas want to identify the virus or viruses precisely. They want to grow the virus in test tubes. But there is a danger in that procedure. A virulent form of the virus could in principle infect the workers. ”We’ve turned our laboratory into Fort Know,” Dr. Grace said at an interview. “You can’t get in and out without taking a shower. We’ve already increased the deadliness of the virus so that it produces cancer in mice ib seven days rather than forty.” This was done by transferring it from animal to animal.

And eventually Dr. Grace looks toward making a preventive vaccine against disease. This can be done either with a killed virus, with the Salk technique, or with a weakened cancer virus. It’s a long way to go Dr. Grace admits, but he never again wants to watch a child die of leukemia.

 

Armstrong Promotes Cancer Research

Associated Press

AUSTIN, Texas - With Lance Armstrong pushing for a record sixth consecutive Tour de France title this summer, his cancer research foundation is using the signature color of the world’s most grueling bicycle race for a new fund-raising campaign. The Lance Armstrong Foundation and Nike are promoting the sale of yellow wristbands engraved with the message, “Live Strong.”

“Yellow has taught me the true meaning of sacrifice. Yellow makes me suffer. Yellow is the reason I’m here,” Armstrong said. “Young people with cancer should be empowered to fight hard, dream big and live strong.”

The company will donate $1 million to the foundation, which hopes to raise an additional $5 million through wristband sales. Proceeds will go to the foundation for programs for young people with cancer. Foundation President Mitch Stoller said officials hope the wristbands will become as recognizable as the pink ribbons associated with breast cancer.

Armstrong overcame advanced testicular cancer that had spread to his lungs and brain. He went from having a 50 percent chance to live in 1996 to a string a five straight tour wins from 1999-2003, forever linking himself with the yellow jersey worn by the tour leader and champion.

 

Postdoctoral Position in Signal Transduction and Cancer

Immediately available in Department of Pathology, Yale University School of Medicine. The applicant must have strong background in molecular biology or immunology or cancer biology. The commitment to basic science research is required.  The applicants with the potential to obtain a fellowship from NIH or other foundations are prefered.

Project will involve studies of signal transduction from cytokine receptors to transcription factor STAT and their possible roles in cancer development.

Background and our Research Interest:

A variety of protein ligands (such as hormones and cytokines) induce activation of protein tyrosine kinases (PTK) and affect gene expression.   Our laboratory working on a recently established signaling pathway involving direct activation of cytoplasmic transcription factors by tyrosine kinases. A direct signaling model of signal transduction has been proposed (Fu, 1992). In this model, the transcription factors (termed STAT) are directly activated by a membrane receptor-associated tyrosine kinase(s) through their   SH2 (Src homology region 2) domains. These activated transcription factors then translocate to the nucleus to join a nuclear protein to form an active transcriptional complex, inducing expression of specific functional proteins.  Most recently, studies from our lab and other laboratories have also demonstrated that Interferons, EGF, PDGF, CSF-1, IL-2, IL-3, IL-4, IL-5, IL-6, and IL-10 etc., all use this direct pathway to control nuclear transcriptional events (reviewed in Darnell et al., 1994). A fundamental question in cancer research is whether and how these signaling pathways are involved abnormal cell growth and transformation of normal cells.  Our current research is aiming to expand our understanding of the signal transduction of cytokines, especially the functions of STAT to the field of cancer immunology which includes STAT function in  cancer development  and in the general cellular immune responses.

 

OT: SETI as opposed to Cancer Research

In a follow-up to Wirt’s remarks regarding Parabon, may I make a comparison between the two cancer research software options that were mentioned on this list.  I am referring to Parabon Pioneer and United Devices, both of which are “profit making adventures, but with completely different results and environments.

I installed Parabon Pioneer on one of my pc’s first.  The installation was quick and painless.  I can locally control how much disk space it uses, how much of the CPU memory it will consume and how long it will wait for my machine to go idle before it grabs control.  If you wish to disable the software for any period of time, it’s a simple as a right click followed by clicking on the “disable engine” option.  In truly does operate in an unobtrusive manner.  Truly it does offer a “pay for use” approach, but any proceeds that you may have earned can be earmarked back to the American Cancer Society and refunneled into cancer research.  As near as I can tell, the software has completed 5 tasks in 6 days - 4 of which were “cancer research” related and 2 of which were apparently something else (what I can’t even fathom).

I also installed United Devices on another pc.  The installation was not quite as fast, but it was pretty painless.  That’s where the similarities end.  The UD software takes about 1/3 more disk space (although at 2.25 megabytes, it’s still not a large amount).  The options are all remotely controlled from their website.  However, it took 5 tries to actually get their website to recognize my options - and then the software still ignores most of my preferences.  The software does not wait for your machine to go idle, but instead also tries to grab “unused cycles” during productive times.  At times I have tracked it consuming as much as 80% of that machine - even when I am doing other normally CPU intensive tasks!  To temporarily disable the software you actually have to exit out of the software - which means that to restart it you have to “reload” it.  It is very intrusive!  Yes, it is a “pay for cycles” approach as well, but from what I can gather the number of tasks that are dedicated to cancer research, it is nearly 100% cancer research related.

It’s really hard to make a choice between these two options, but I think because of the “unobtrusiveness of the software I will continue with Parabon and drop the UD stuff - on all of my machines.

 

Cancer Research Campaign supports “selling” stars!

The Cancer Research Campaign has joined forces with a ‘Star selling’ company to persuade people that they can buy a star from the CRC and have it named after a loved one, and that the ‘profit’ goes to research. Lawrence Harris wrote in message. The Cancer Research Campaign has joined forces with a ‘Star selling’ company to persuade people that they can buy a star from the CRC and have it named after a loved one, and that the ‘profit’ goes to research.

I personally have no problem with this, provided that the buyers are aware that all they’re buying is a pretty certificate and that the name has no “official” standing. At the end of the day, it’s just another way for a very worthy cause to raise extra funds.

The secretary of the PAS wrote a detailed critique of the CRC claims but the spokewoman refused to answer any of the points except to “assure” Alan that they were happy to get money in this way.  Her assurance was gibberish.  They are actually claiming that the certificates are valid and meaningful.  I strongly object to fraud (having been a victim of fraud myself) and that is exactly what the CRC is doing.  The victims genuinely believe the stars have a new name by ‘virtue’ of payment.  Were I to ‘sell’ certificates showing local roads renamed (for loved ones) you can imagine the public outcry.  Fraud is fraud and the means cannot justify the ends.

Join the Cancer Research Dialog

Are you interested in joining a dialog about Cancer Research? Are you or do you know someone who is a cancer patient, survivor or victim? Or does your work involve cancer? Do you work in cancer research? Is cancer research succeeding? Are we devoting enough resources to it? Can all cancers be cured at all, and if so when?

Current discussion points include
- the search for a cure
- the costs and future of traditional and non-traditional cancer research
- whether cancer is on the rise.
There are questionnaires to fill out if you like, and any comments are welcome and will be posted. If you’d like to see other discussion points, they could be added. There is also something I call the Interface, where you can ask any questions of cancer researchers - or if you are a researcher, you can
volunteer to answer questions.

 

New York state taxpayers can donate to prostate cancer research

Starting in 2005, New Yorkers can contribute to prostate cancer research by checking off a donation on their state tax returns. With financier Michael Milken at his side, Gov. George Pataki signed a bill into law Tuesday providing for the new prostate cancer check off. The governor announced that for every dollar New York taxpayers donate, Milken’s Prostate Cancer Foundation will contribute a dollar.

Of the 230,000 men diagnosed nationally with prostate cancer this year, nearly 30,000 will die. Milken, who was diagnosed with the disease 11 years ago, said the outcomes of cases continue to improve, especially when it’s discovered early. “We’ve made important progress in prevention, detection and treatment of this devastating disease,” Milken said. “But time is not on our side as baby boomers are reaching the age at which the rate of prostate cancer rises quickly.” State officials had no estimate for how much money would be donated through the check off. There are five other donation boxes on current state income tax returns, including opportunities to contribute to breast cancer and Alzheimer’s disease research. The check off boxes raise about $1.5 million a year in overall contributions, state Tax Commissioner Andrew Eristoff said.
State Senate Majority Leader Joseph Bruno said the legislation signed Tuesday grew out of a round-table on prostate cancer co-hosted by Milken and the senator earlier this year. Bruno underwent treatment for prostate cancer in 2003 and said he’s been declared cancer-free by doctors. Bruno said men are not as diligent as women about getting regular medical checkups or at aggressively seeking medical care when they suspect they have a health problem. Donald Distasio, CEO for the American Cancer Society’s eastern division, said Bruno’s candor about his condition and his treatment undoubtedly caused many men across the state to get screened for prostate cancer. According to the state’s health commissioner, Dr. Antonia Novello, about 1 in 6 men will get prostate cancer and about 1 in 8 women will get breast cancer. She said the death rates are almost identical. Milken beat his cancer despite being given 12 months to live when it was first diagnosed in 1993. The one-time “junk bond king,” Milken served two years in prison for securities crimes. He has long been a leading philanthropist, founding the Milken Family Foundation in 1982 and the Prostate Cancer Foundation in 1993.

 

Idea to raise money for Cancer research

Our very own Dan Kuryliak is starting aggressive chemo treatment for cancer today. He has diffused B cell lymphoma . Apparently the chemo cocktail that he is going to get will cause his hair to get a lot thinner. Here is what I propose, those that are brave enough will donate $5.00 to have a really tight brush cut, or completely shaved up to them. The money we raise will be donated to Cancer research. Then the receipt can be auctioned off, or tickets sold, to a lucky person.

This will be open to both men and women. Ideas and comments are appreciated and welcomed. We need to do this soon and hopefully with some media coverage as well so we can have an impact on the popular misconception about bikers. If a bunch of ott.motorcyclists, or even just Ken, volunteer to have their head, and beard if they have one, shaved to raise money for cancer research, then I will donate a fair bit more than $5.  However, if you think I’m ugly with my beard, and who wouldn’t (if you’re female call me!), you don’t want to see me without the beard: kids cry, women shriek, men just laugh and point!

Ken, keep track of name and address of donaters, and give this info to the Cancer Research Centre with the money so they issue tax receipts.  Do this and I will donate $100.

 

 

Huge Cancer Research Project Linking PCs Is Launched

Cancer researchers want to turn your personal computer’s screen saver into a life saver. A project launched on Tuesday aims to link millions of personal computers over the Internet to accelerate research for new drugs to treat leukemia, with a goal of cutting nearly in half the time needed to bring the new drugs to market.

If successful, it will be the world’s largest ever computing project and will be a virtual super-computer capable of more than 50 trillion operations per second — or roughly 10 times as powerful as the world’s biggest supercomputer.

The joint venture partners — Oxford University, the U.S. technology company United Devices, the American Cancer Society, and the National Foundation for Cancer Research — and project sponsor chipmaker Intel Corp. announced the project at a news conference on Tuesday at Intel’s Santa Clara, Calif. headquarters. The goal, they said, is to have 6 million PCs involved in the project — called the Intel Philanthropic Peer-to-Peer Program — this year.

The research aims to exploit unused power from PCs to process information on molecules and send it back to a central server at United Devices’ Austin, Texas headquarters, which would then pass on the data to Oxford. The information on those molecules could then eventually be parlayed into new drugs.

 

Jomol: An Investment Opportunity in Cancer Research

Jomol is a medical research company focusing on cancer research. We have discovered a nontoxic, natural, immunological cancer treatment which we have been advancing rapidly for the last 20 years. The product has already shown great success in real-life studies — we have treated more than 1600 (mostly final-case) patients with exceptional results — some of them making medical history! We have received official allowances for our treatment in Georgia (former USSR), with further allowances pending. We feel our business is at the crossroads of changing from a research product to a real-life treatment. Our researchers are Europe¹s finest and we have received recognition for our research in the form of awards and collaboration and approval from top European universities plus we hold several European and world patents.

Our main shortfall (and the reason for this appeal) is that although our organization is composed of great scientists, we have little business knowledge (this marketing itself has been a gift from a friend). We need people who have the resources and skills to bring our discovery to the world. We are confident that we have found something revolutionary; we have documented proof and will supply any seriously interested investor with further information. We are seeking investors who are looking for a business opportunity but also want to do something good and productive for the world. If you are not in a position to act on this now but you care about this issue, you can help by forwarding this message to anyone you think may be able to help. For the business minded, the potential profits are enormous as our treatments are brought to the market. In return, we ask that you treat us fairly and simply allow us the recognition we deserve.